4D Molecular Therapeutics (FDMT)
(Real Time Quote from BATS)
$11.35 USD
-0.55 (-4.62%)
Updated Sep 23, 2024 11:36 AM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.67 | 0.00% |
Earnings Summary
For their last quarter, 4D Molecular Therapeutics (FDMT) reported earnings of -$0.63 per share, beating the Zacks Consensus Estimate of $-0.72 per share. This reflects a positive earnings surprise of 12.50%. Look out for FDMT's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.67 per share, reflecting a year-over-year decrease of 179.17%.
Earnings History
Price & Consensus
Zacks News for FDMT
4D Molecular Therapeutics (FDMT) Loses -21.87% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
FDMT: What are Zacks experts saying now?
Zacks Private Portfolio Services